Sodium Bicarbonate Recovery Randomized Trial: What the Evidence Says

Quick Answer

Sodium Bicarbonate Recovery Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 preclinical study, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Acute kidney injury (AKI) is common in critically ill patients and is associated with significant morbidity and mortality. [Kada Klouche (2026); evidence level 4]
• RRT remains a major challenge in intensive care unit (ICU) and its use is associated with high mortality rate, which can reach 30-50%. [Kada Klouche (2026); evidence level 4]
• Seventy of 109 patients (64%) in the "on-demand" group achieved recovery compared with 55 of 109 patients (50%) in the conventional group (absolute risk difference 13.8%; 95% CI, 0.8%-26.8%; P=.04). [Garsuta Cani Greg L. (2026); evidence level 4]
• The "on-demand" group received significantly fewer weekly sessions (median 1.8 vs 3.1) and experienced fewer episodes of dialysis-associated hypotension (69 vs 97 events). [Garsuta Cani Greg L. (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For sodium bicarbonate recovery randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Kada Klouche (2026). Renal replacement therapy in intensive care unit: a narrative review. DOI: 10.1016/j.aicoj.2026.100080. PMCID: PMC13200139. PMID: 42199841. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13200139/
• Garsuta Cani Greg L. (2026). Updates in Hospital Medicine: Nephrology. DOI: 10.56305/001c.159167. PMCID: PMC13048828. PMID: 41940226. License: https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Attribution-NonCommercial License (4.0) This is an o.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13048828/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.